PATENT CLAIM ANALYSIS

Application Number: 16155861
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to a 2,4-disubstituted pyrimidine derivative and the use thereof as a therapeutically effective cyclin-dependent kinase (CDK) inhibitor. In particular, the present disclosure relates to the use of a new 2,4-disubstituted pyrimidine derivatives shown in formula (I) and a pharmaceutical composition thereof as a selective CDK4/6 inhibitor in preventing or treating diseases related to CDK4/6.

Claim (Index 2):
The 2,4-disubstituted pyrimidine derivative according to  claim 1 , wherein the C 1 -C 3  alkyl is methyl, ethyl, n-propyl, or iso-propyl, and the C 1 -C 5  alkyl is methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-3-butyl, 1,1-dimethyl-1-propyl, or 2,2-dimethyl-1-propyl.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.54762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16155867', '15764884', '15328813', '12843494', '11690305']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7507286972955391
- 35 USC 102 Novelty (BERT): 0.5237635246436052
- Combined Prediction Score: 0.7280321800303459
- Mean Citation Score: 279.08915
- Max Citation Score: 322.41934
- Similarity Product: 281.8075945580673

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test